THE LIBRARY / METABOLIC HEALTH
Semaglutide
A GLP-1 receptor agonist
Established clinical use
ILLUSTRATION · NOT A PRODUCTA peptide-based prescription medicine with FDA-approved products for specific conditions.
What it is
Semaglutide acts on the GLP-1 receptor. FDA-approved products have specific indications, formulations, and labeling.
What the evidence says
Clinical trials support approved uses, including type 2 diabetes and, for certain products and patients, chronic weight management.
What remains uncertain
Evidence for an approved product does not automatically apply to an unapproved formulation, a different dose, or a different population.
Primary sources
This page is for education only. It is not medical advice, a treatment recommendation, or a guide to obtaining or using a peptide. Speak with a qualified clinician about personal health decisions.